# Bioequivalence Study of Metformin Hydrochloride Extended-Release Tablets USP 750 mg Under Fed Condition

> **NCT01831674** · PHASE1 · COMPLETED · sponsor: **IPCA Laboratories Ltd.** · enrollment: 48 (actual)

## Conditions studied

- Fasting

## Interventions

- **DRUG:** Metformin Hydrochloride Extended-Release Tablets USP 750
- **DRUG:** GLUCOPHAGE®XR tablet 750 mg

## Key facts

- **NCT ID:** NCT01831674
- **Lead sponsor:** IPCA Laboratories Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2012-12
- **Final completion:** 2013-02
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2013-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01831674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01831674, "Bioequivalence Study of Metformin Hydrochloride Extended-Release Tablets USP 750 mg Under Fed Condition". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01831674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*